Literature DB >> 27121486

Relationship between XspI Site Polymorphisms of LDL-R Gene and Serum IL-2 and IL-10 in Patients with Hypercholesterolemia.

Mingming Zhang1, Yamin Lu2, Xin Liu3, Xiaobin Zhang4, Cuigai Zhang5, Wei Gao6, Yanqing Tie6.   

Abstract

BACKGROUND: Relationship has been identified in sporadic reports between polymorphisms and hypercholesterolemia. However, the relationship between inflammatory cytokines and polymorphism of low-density lipoprotein receptor (LDL-R) gene in hypercholesterolemia is unclear. This study aimed to explore the relationship and significance between polymorphisms of LDL-R gene and serum Interleukin-2 (IL-2), IL-10 in patients with hypercholesterolemia.
METHODS: PCR-RFLP and direct DNA sequencing assay were employed to determine polymorphism of LDL-R gene in 900 patients with hypercholesterolemia and 400 healthy cases. ELISA was applied to assay serum concentration of IL-2 and IL-10. Blood lipid indexes were tested in all cases.
RESULTS: Compared with the healthy controls, level of IL-2 increased significantly, while IL-10 decreased significantly (P < 0.05). Correlation analysis showed that IL-2 was positively correlated with total cholesterol (TC), LDL-c, and genotype (r = 0.542, 0.410, 0.598, P < 0.05) and negatively correlated with HDL-c (r = -0.352, P < 0.05). Negative relationship also was found between TC, LDL-c, genotype, and IL-10 (r = -0.452, -0.390, -0.613, P < 0.05), and positive correlation between HDL-c and IL-10 (r = 0.398, P < 0.05). Multiple linear regression showed that genotypes and TC were independent factors affecting the levels of IL-2 and IL-10 (P < 0.05).
CONCLUSION: IL-2 and IL-10 were related to gene polymorphisms of LDL-R, which might be involved in the development and progress of hypercholesterolemia.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  gene polymorphisms; hypercholesterolemia; interleukin-10; interleukin-2; low-density lipoprotein receptor

Mesh:

Substances:

Year:  2016        PMID: 27121486      PMCID: PMC6807227          DOI: 10.1002/jcla.21991

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

1.  Association between serum soluble low-density lipoprotein receptor levels and metabolic factors in healthy Japanese individuals.

Authors:  Hisashi Shimohiro; Shin-Ichi Taniguchi; Masahiko Koda; Chieko Sakai; Sadako Yamada
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.

Authors:  Thore Dietrich; Thomas Hucko; Christiane Schneemann; Marleen Neumann; Andreas Menrad; Joerg Willuda; Kirstin Atrott; Dietger Stibenz; Eckart Fleck; Kristof Graf; Hans D Menssen
Journal:  Atherosclerosis       Date:  2011-10-05       Impact factor: 5.162

3.  Interleukin 2 targeted therapy in inflammatory bowel disease.

Authors:  S Yarkoni; Y Sagiv; A Kaminitz; N Askenasy
Journal:  Gut       Date:  2009-12       Impact factor: 23.059

Review 4.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

5.  SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet.

Authors:  Francesco Potì; Uta Ceglarek; Ralph Burkhardt; Manuela Simoni; Jerzy-Roch Nofer
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

Review 6.  Role of interleukin-2 in patients with HIV infection.

Authors:  Sarah L Pett; Anthony D Kelleher; Sean Emery
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

7.  Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.

Authors:  Daniel Kolbus; Maria Wigren; Irena Ljungcrantz; Ingrid Söderberg; Ragnar Alm; Harry Björkbacka; Jan Nilsson; Gunilla N Fredrikson
Journal:  Immunobiology       Date:  2010-11-19       Impact factor: 3.144

8.  Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis.

Authors:  Maik Drechsler; Remco T A Megens; Marc van Zandvoort; Christian Weber; Oliver Soehnlein
Journal:  Circulation       Date:  2010-10-18       Impact factor: 29.690

9.  Homocysteine and pro-inflammatory cytokine concentrations in acute heart disease.

Authors:  Cahide Gokkusu; Feti Tulubas; Yesim Unlucerci; Elif Ozkok; Berrin Umman; Makbule Aydin
Journal:  Cytokine       Date:  2010-02-02       Impact factor: 3.861

10.  Magnetic resonance imaging of bone marrow cell-mediated interleukin-10 gene therapy of atherosclerosis.

Authors:  Jihong Sun; Xubin Li; Hongqing Feng; Huidong Gu; Tiffany Blair; Jiakai Li; Stephanie Soriano; Yanfeng Meng; Feng Zhang; Qinghua Feng; Xiaoming Yang
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

View more
  1 in total

1.  Upregulated expression of human cathelicidin LL-37 in hypercholesterolemia and its relationship with serum lipid levels.

Authors:  Yun-Xi Li; Bao-Zhen Li; Da-Zun Yan
Journal:  Mol Cell Biochem       Date:  2018-04-11       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.